Equillium, Inc. (EQ) vs VAXART, INC. (VXRT)
- Equillium, Inc. EQ 1.41 −2.08%
- VAXART, INC. VXRT 0.43 0.00%
Equillium, Inc. and VAXART, INC. are both Biotechnology companies. Equillium, Inc. and VAXART, INC. are of similar size ($92.4M and $91.3M). Equillium, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against 13.9%. VAXART, INC. has the higher net margin (15.9% vs 0.00%) and the higher return on invested capital (134.6% vs 0.00%). Across the 15 metrics below, VAXART, INC. leads on 14 and Equillium, Inc. on 1.
Valuation
Profitability
| Metric | EQ | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 16.30% | 0.00% |
| Net margin | 0.00% | 15.88% | 0.00% |
| Free cash flow margin | 0.00% | 13.74% | 0.00% |
| Return on equity | (58.98%) | 66.97% | (56.66%) |
| Return on assets | (50.68%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack